Steven W. Spector
2013
In 2013, Steven W. Spector earned a total compensation of $2.3M as Executive Vice President, General Counsel and Secretary at Arena Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $203,673 |
|---|---|
| Option Awards | $392,290 |
| Salary | $395,000 |
| Stock Awards | $1,290,600 |
| Other | $16,041 |
| Total | $2,297,604 |
Spector received $1.3M in stock awards, accounting for 56% of the total pay in 2013.
Spector also received $203.7K in non-equity incentive plan, $392.3K in option awards, $395K in salary and $16K in other compensation.
Rankings
In 2013, Steven W. Spector's compensation ranked 3,420th out of 12,286 executives tracked by ExecPay. In other words, Spector earned more than 72.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,420 out of 12,286 | 72nd |
Division Manufacturing | 1,154 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 310 out of 1,462 | 79th |
Industry group Drugs | 214 out of 1,156 | 82nd |
Industry Pharmaceutical Preparations | 176 out of 890 | 80th |
Source: SEC filing on April 28, 2016.
Spector's colleagues
We found five more compensation records of executives who worked with Steven W. Spector at Arena Pharmaceuticals in 2013.
2013
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2013
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2013
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2013
Robert Hoffman
Arena Pharmaceuticals
Chief Financial Officer
2013
Harry Hixson
Arena Pharmaceuticals